Harmine alleviates atherogenesis by inhibiting disturbed flow-mediated endothelial activation via protein tyrosine phosphatase PTPN14 and YAP.
Yujie YangQiannan MaZhiyu LiHui WangChenghu ZhangYajin LiuBochuan LiYingmei WangQinghua CuiFengxia XueDing AiYi ZhuJinlong HePublished in: British journal of pharmacology (2021)
Harmine alleviated OSS-induced EC activation via a PTPN14/YAPY357 pathway and had a potent atheroprotective role.